Check-Cap (CHEK) Starts Presentation at LD Micro Main Event
Check-Cap (NASDAQ: CHEK) is a clinical-stage medical diagnostics company that engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the screening for precancerous polyps and cancer. Its products include an ingestible capsule with a colon imaging system for colorectal cancer and pre-cancerous polyps that utilizes X-ray-based technology to generate 3-dimensional imagery of the colon without cleansing or other aggressive bowel preparation. For more information, visit the company's website at www.check-cap.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial…







